EU regulators and industry clash on pharmaceutical reform package
European Union officials said a proposal to reform the EU pharmaceutical legislation will go a long way towards providing equal access to new medicines, yet the proposal faced pushback from representatives of pharmaceutical companies who argued that shortening the marketing exclusivity periods for new drugs will hurt innovation and stymie clinical research in the region.
More information on Regulatory Focus Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (3 octobre 2024). EU regulators and industry clash on pharmaceutical reform package. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/12etk





